Tamsulosin and Relapsing-remitting multiple sclerosis - a phase IV clinical study of FDA data
Summary:
Relapsing-remitting multiple sclerosis is reported as a side effect among people who take Tamsulosin (tamsulosin), especially for people who are male, 40-49 old, also take Ativan, and have Secondary progressive multiple sclerosis.
The phase IV clinical study analyzes which people have Relapsing-remitting multiple sclerosis when taking Tamsulosin. It is created by eHealthMe based on reports of 70,950 people who have side effects when taking Tamsulosin from the FDA, and is updated regularly.
What is Tamsulosin?
Tamsulosin has active ingredients of tamsulosin. It is often used in prostate examination abnormal. eHealthMe is studying from 72,635 Tamsulosin users. Check the latest studies of Tamsulosin.
What is Relapsing-remitting multiple sclerosis?
Relapsing-remitting multiple sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged) is found to be associated with 127 drugs and 177 conditions by eHealthMe. Check the latest studies of Relapsing-remitting multiple sclerosis.
70,950 people reported to have side effects when taking Tamsulosin.
Among them, 149 people (0.21%) have Relapsing-remitting multiple sclerosis.
Among these 149 people:
What is the gender of people who have Relapsing-remitting multiple sclerosis when taking Tamsulosin? *
What is the age of people who have Relapsing-remitting multiple sclerosis when taking Tamsulosin? *
What are other drugs people take besides Tamsulosin? *
What are other side effects people have besides Relapsing-remitting multiple sclerosis? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Tamsulosin and have Relapsing-remitting multiple sclerosis?
- Check whether Relapsing-remitting multiple sclerosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Tamsulosin:
- Tamsulosin (72,635 reports)
Relapsing-remitting multiple sclerosis treatments and more:
- Relapsing-remitting multiple sclerosis (76,275 reports)
How severe was Relapsing-remitting multiple sclerosis and when was it recovered:
Expand to all the drugs that have ingredients of tamsulosin:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Tamsulosin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Relapsing-remitting multiple sclerosis:
- Relapsing-remitting multiple sclerosis (127 drugs)
Browse all the conditions that are associated with Relapsing-remitting multiple sclerosis:
- Relapsing-remitting multiple sclerosis (177 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on tamsulosin (the active ingredients of Tamsulosin) and Tamsulosin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Flomax cause Purulent Discharge? - now
- Drug interactions of Aloe and Xarelto - 2 seconds ago
- Drug interactions of Tamsulosin and Mupirocin - 4 seconds ago
- Drug interactions of Coreg and Famotidine - 9 seconds ago
- Drug interactions of Guaifenesin and Diflucan - 10 seconds ago
- Drug interactions of Guaifenesin and Acidophilus - 14 seconds ago
- Drug interactions of Tamsulosin and Propofol - 15 seconds ago
- Drug interactions of Zofran and Savella - 18 seconds ago
- Could Eupressyl cause Acute Pulmonary Oedema? - 20 seconds ago
- Could Vicoprofen cause Dyspnea Exacerbated? - 21 seconds ago